Developer docs
API playgroundTry for free, no card

Search company profiles

Biognostica Lda

Full company profile

uuid003zl7p

Namestring
Biognostica Lda
Websiteurl
biognostica.pt
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Biognostica Lda is a Portuguese private entity, as indicated by its ".pt" top-level domain (biognostica.pt) and the "Lda" suffix denoting a Portuguese limited-liability company equivalent. The company name suggests an orientation toward biological diagnostics or bioanalytical products, but no substantive confirmation of products, services, or technical focus is available from the source material.

The only retrievable corporate information consists of a verification/loading placeholder page from the company website, which provides no content on products, technologies, customers, team, history, or pricing. All structured fields — products, services, integrations, AI capabilities, certifications, partnerships, customers, funding, leadership, headcount, locations, and pricing — are empty in the input.

The company appears to be privately held, with no disclosed ownership, parent entity, or investor base. No operating geographies, customer segments, distribution channels, or go-to-market signals could be confirmed. Accordingly, any forward-looking assessment of model, scale, or strategy cannot be grounded in observable evidence and has been left as 'unknown' throughout this profile.

Short descriptiontext

Biognostica Lda is a Portuguese limited-liability company operating under the biognostica.pt domain. Its corporate function, products, and customer base cannot be determined from currently available source data, which consists only of a verification/loading placeholder page.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
biological diagnostics, life sciences products, bioscience supplies, laboratory reagents, scientific consumables
Industry2 codes
1Proteomics & Mass Spectrometry Services
CodeHLAGANABPrimaryYes
2Molecular Diagnostics (PCR/qPCR, NGS-based assays)
CodeHLAAALAAPrimaryNo
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Social media profiles1 record
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

No substantive information about the company's core offerings could be evidenced from the source content. The source page (biognostica.pt) is a verification/loading page with no products, services, or offering details disclosed. The company name "Biognostica" suggests a focus on biological diagnostics or bioscience-related products, but no factual description of core offerings can be supported from the available input.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeBroad incumbent
Description

Major diagnostic and laboratory solutions provider; comparable as a broad incumbent in clinical lab testing whose products flow through regional distributors.

TypeBroad incumbent
Description

IVD company focused on immunodiagnostics and molecular diagnostics; comparable incumbent whose specialty reagents are commonly channeled through regional distributors.

TypeBroad incumbent
Description

Global life science tools and clinical diagnostics manufacturer covering proteomics, molecular diagnostics, and IVD reagents; comparable as a potential upstream supplier/partner to a Portugal-based diagnostic distributor.

TypeBroad incumbent
Description

Diagnostics and women's health player with molecular diagnostics franchises; comparable as a specialty IVD vendor active in the same distributor ecosystem.

TypeRegional player
Description

Spain-headquartered diagnostics and plasma-derived therapeutics company; relevant as a regional player addressing the same Iberian clinical diagnostics market.

TypeBroad incumbent
Description

In vitro diagnostics specialist in microbiology and industrial applications; comparable broad incumbent operating in the same IVD reagent category.

TypeBroad incumbent
Description

Provider of molecular diagnostics and life-science sample technologies; relevant as both a peer and a potential principal brand that a Portuguese diagnostics distributor could carry.

TypeBroad incumbent
Description

Global IVD leader spanning molecular, clinical chemistry, and immunoassays; comparable as an incumbent whose product lines a Portuguese specialty distributor could resell or complement.

TypeBroad incumbent
Description

Largest life-science tools and diagnostics conglomerate; relevant incumbent and probable supplier to specialty diagnostic distributors in Southern Europe.

TypeBroad incumbent
Description

Broad IVD portfolio (molecular, immunoassay, point-of-care); relevant incumbent for the same diagnostic channel/distribution adjacency.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks3 records

Each record includes

Headline, Details, Source

Key highlights2 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biognostica Lda

Biognostica Lda is a Portuguese limited-liability company operating under the biognostica.pt domain. Its corporate function, products, and customer base cannot be determined from currently available source data, which consists only of a verification/loading placeholder page.

What Biognostica Lda does

Biognostica Lda is a Portuguese private entity, as indicated by its ".pt" top-level domain (biognostica.pt) and the "Lda" suffix denoting a Portuguese limited-liability company equivalent. The company name suggests an orientation toward biological diagnostics or bioanalytical products, but no substantive confirmation of products, services, or technical focus is available from the source material.

The only retrievable corporate information consists of a verification/loading placeholder page from the company website, which provides no content on products, technologies, customers, team, history, or pricing. All structured fields — products, services, integrations, AI capabilities, certifications, partnerships, customers, funding, leadership, headcount, locations, and pricing — are empty in the input.

The company appears to be privately held, with no disclosed ownership, parent entity, or investor base. No operating geographies, customer segments, distribution channels, or go-to-market signals could be confirmed. Accordingly, any forward-looking assessment of model, scale, or strategy cannot be grounded in observable evidence and has been left as 'unknown' throughout this profile.

Biognostica Lda firmographics

Firmographics
Name
Biognostica Lda
Website
https://biognostica.pt
Company type
Private
Headcount range
1–10 employees
Short description
Biognostica Lda is a Portuguese limited-liability company operating under the biognostica.pt domain. Its corporate function, products, and customer base cannot be determined from currently available source data, which consists only of a verification/loading placeholder page.
Ownership category
akta.pro rank

Biognostica Lda industry classification

Industry
NAICS
Medical Laboratories (621511)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Proteomics & Mass Spectrometry Services (HLAGANAB)
akta.pro secondary industry
Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

Keywords

  • Biological diagnostics
  • Life sciences products
  • Bioscience supplies
  • Laboratory reagents
  • Scientific consumables

Biognostica Lda business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Biognostica Lda product offering

Product offering

Core offering

No substantive information about the company's core offerings could be evidenced from the source content. The source page (biognostica.pt) is a verification/loading page with no products, services, or offering details disclosed. The company name "Biognostica" suggests a focus on biological diagnostics or bioscience-related products, but no factual description of core offerings can be supported from the available input.

Differentiator

Problem solved

Functional benefit

Companies that use Biognostica Lda

Customer profile

Ideal customer profiles1 record

Biognostica Lda technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Biognostica Lda competitors and assessment

Company assessment

Broad incumbents

  • Siemens Healthineers: Major diagnostic and laboratory solutions provider; comparable as a broad incumbent in clinical lab testing whose products flow through regional distributors.
  • DiaSorin: IVD company focused on immunodiagnostics and molecular diagnostics; comparable incumbent whose specialty reagents are commonly channeled through regional distributors.
  • Bio-Rad Laboratories: Global life science tools and clinical diagnostics manufacturer covering proteomics, molecular diagnostics, and IVD reagents; comparable as a potential upstream supplier/partner to a Portugal-based diagnostic distributor.
  • Hologic: Diagnostics and women's health player with molecular diagnostics franchises; comparable as a specialty IVD vendor active in the same distributor ecosystem.
  • bioMérieux: In vitro diagnostics specialist in microbiology and industrial applications; comparable broad incumbent operating in the same IVD reagent category.
  • QIAGEN: Provider of molecular diagnostics and life-science sample technologies; relevant as both a peer and a potential principal brand that a Portuguese diagnostics distributor could carry.
  • Roche Diagnostics: Global IVD leader spanning molecular, clinical chemistry, and immunoassays; comparable as an incumbent whose product lines a Portuguese specialty distributor could resell or complement.
  • Thermo Fisher Scientific: Largest life-science tools and diagnostics conglomerate; relevant incumbent and probable supplier to specialty diagnostic distributors in Southern Europe.
  • Abbott Diagnostics: Broad IVD portfolio (molecular, immunoassay, point-of-care); relevant incumbent for the same diagnostic channel/distribution adjacency.

Regional players

  • Grifols: Spain-headquartered diagnostics and plasma-derived therapeutics company; relevant as a regional player addressing the same Iberian clinical diagnostics market.

Market position

Strengths1 record

Weaknesses2 records

Competitive moat1 record

Key risks3 records

Key highlights2 records

Customer concentration

Biognostica Lda social profiles

Digital presence

Biognostica Lda financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biognostica Lda leadership team

Management profile

Number of profiles

Biognostica Lda funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biognostica Lda M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biognostica Lda

What does Biognostica Lda do?

No substantive information about the company's core offerings could be evidenced from the source content. The source page (biognostica.pt) is a verification/loading page with no products, services, or offering details disclosed. The company name "Biognostica" suggests a focus on biological diagnostics or bioscience-related products, but no factual description of core offerings can be supported from the available input.

Is Biognostica Lda a public or private company?

Biognostica Lda is a private company.

When was Biognostica Lda founded?

Biognostica Lda was founded in -1. It employs 1 to 10 people.

Who are Biognostica Lda's main competitors?

Broad incumbents on record are Siemens Healthineers, DiaSorin, Bio-Rad Laboratories, Hologic, bioMérieux, QIAGEN, Roche Diagnostics, Thermo Fisher Scientific and Abbott Diagnostics. Grifols is listed as a regional player.

Does Biognostica Lda have an API?

No public API is recorded for Biognostica Lda.

What industry is Biognostica Lda in?

Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 621511 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales